09-10-2019 | 17:30

The 9th Arbitration Appeal Court in Moscow confirmed legitimacy of FAS decision.  FAS estimates that the cartel revenue exceeded 2 billion RUB


In February 2019, FAS found that “Regionapharm” Ltd., “Globalmedtekh” Ltd.,  “Dagmedtekhnika” Ltd., “Medpharmsnab” Ltd. maintained prices at auctions for supplying drugs and medical products to medical facilities and the Ministry of Healthcare of the Dagestan Republic in 2015 - 2018.


FAS also concluded that the companies - cartel members and the Ministry of Healthcare of the Dagestan Republic, “Republican Oncology Early Treatment Clinic” State Budgetary Establishment of the Dagestan Republic concluded an anticompetitive agreement between the ordering party and bidders (Clause 1 Part 1 Article 17 of the Federal Law “On Protection of Competition”).


The cartel members are held administratively liable. The total administrative fines exceeded 116 million RUB.


Criminal proceedings are opened against a former Minister of Healthcare of the Dagestan Republic and cartel members.


Head of FAS Anti-Cartel Department, Andrey Tenishev, emphasized: “Cartels and collusions with government customers in the healthcare sector damage consumers as well as the state. One the one hand, they threaten health of the population since cartel members and public customers in such cases worry only about their self-interests  rather than the quality of medicinal drugs and supplying everything necessary to medical facilities. On the other, there is no competition at auctions, which results in inefficient allocation so budgetary funds”.


Site Map

News & Events Press Releases Media Releases Image Library About the FAS Russia What We Do General Information Mission, Goals, Values Priority Setting Institutional Memory Stakeholders Engagement Center for Education and Methodics Our History Our Structure Powers of Head and Deputy Heads Our Ratings GCR Using our website International Cooperation Treaties & Agreements International Working Groups Working Group on Research of Competition Issues in the Market of International Telecommunications (Roaming) Meetings Working Group for Studying Competition Problems in the Pharmaceutical Sector Concept Note Meetings OECD Competition Committee OECD meetings 2013 OECD meetings 2014 OECD meetings 2015 OECD meetings 2016 OECD meetings 2017 OECD meetings 2018 FAS Annual Reports OECD-GVH RCC RCC Newsletter ICAP Council on Advertising Headquarters for Joint Investigations UNCTAD 13th session IGE UNCTAD Resolution Russian contributions 14th session IGE UNCTAD Resolution Russian contributions 15th session IGE UNCTAD 16th session IGE UNCTAD 17th session IGE UNCTAD EEU Model Law on Competition ICN BRICS BRICS Conferences Documents BRICS Coordination Committee on antimonopoly policy BRICS Working Groups for the research of competition issues in socially important markets Cooperation within the BRICS BRICS Coordination Committee on antimonopoly policy EU APEC Competition Policy and Law Group Annual meetings Projects ERRA Full Members Organizational Structure Archive Working Group on Investigating Issues on Pricing in the Oil and Oil Product Markets and Methods of their Functioning Meetings Document Library Legislation Reports & Analytics Cases & decisions Contacts Give feedback Contact us Links Authorities Worldwide COVID-19